291 related articles for article (PubMed ID: 29669112)
1. A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens.
Zeller A; Pfuhler S; Albertini S; Bringezu F; Czich A; Dietz Y; Fautz R; Hewitt NJ; Kirst A; Kasper P
Mutagenesis; 2018 Apr; 33(2):179-193. PubMed ID: 29669112
[TBL] [Abstract][Full Text] [Related]
2. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo.
Kirkland D; Speit G
Mutat Res; 2008 Jul; 654(2):114-32. PubMed ID: 18585956
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens.
Morita T; Hamada S; Masumura K; Wakata A; Maniwa J; Takasawa H; Yasunaga K; Hashizume T; Honma M
Mutat Res Genet Toxicol Environ Mutagen; 2016 May; 802():1-29. PubMed ID: 27169373
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
6. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
[TBL] [Abstract][Full Text] [Related]
7. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
8. In vivo genotoxicity testing strategies: Report from the 7th International workshop on genotoxicity testing (IWGT).
Kirkland D; Uno Y; Luijten M; Beevers C; van Benthem J; Burlinson B; Dertinger S; Douglas GR; Hamada S; Horibata K; Lovell DP; Manjanatha M; Martus HJ; Mei N; Morita T; Ohyama W; Williams A
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403035. PubMed ID: 31699340
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
10. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
[TBL] [Abstract][Full Text] [Related]
11. Results of the International Validation of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: Individual data for 1,2-dibromoethane, p-anisidine, and o-anthranilic acid in the 2nd step of the 4th phase Validation Study under the JaCVAM initiative.
Takasawa H; Takashima R; Narumi K; Kawasako K; Hattori A; Kawabata M; Hamada S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Jul; 786-788():144-50. PubMed ID: 26212305
[TBL] [Abstract][Full Text] [Related]
12. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
13. Search for the optimal genotoxicity assay for routine testing of chemicals: Sensitivity and specificity of conventional and new test systems.
Mišík M; Nersesyan A; Ferk F; Holzmann K; Krupitza G; Herrera Morales D; Staudinger M; Wultsch G; Knasmueller S
Mutat Res Genet Toxicol Environ Mutagen; 2022 Sep; 881():503524. PubMed ID: 36031336
[TBL] [Abstract][Full Text] [Related]
14. Performance of comet and micronucleus assays in metabolic competent HepaRG cells to predict in vivo genotoxicity.
Le Hégarat L; Mourot A; Huet S; Vasseur L; Camus S; Chesné C; Fessard V
Toxicol Sci; 2014 Apr; 138(2):300-9. PubMed ID: 24431211
[TBL] [Abstract][Full Text] [Related]
15. Multiple-endpoint genotoxicity assay for colon carcinogen 1,2-dimethylhydrazine.
Hori H; Shimoyoshi S; Tanaka Y; Momonami A; Masumura K; Yamada M; Fujii W; Kitagawa Y; Hayashi M
Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503130. PubMed ID: 32087857
[TBL] [Abstract][Full Text] [Related]
16. Use of in vivo/in vitro unscheduled DNA synthesis for identification of organ-specific carcinogens.
Furihata C; Matsushima T
Crit Rev Toxicol; 1987; 17(3):245-77. PubMed ID: 3556021
[TBL] [Abstract][Full Text] [Related]
17. Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation.
Vasquez MZ
Mutagenesis; 2010 Mar; 25(2):187-99. PubMed ID: 19969526
[TBL] [Abstract][Full Text] [Related]
18. A comparison of transgenic rodent mutation and in vivo comet assay responses for 91 chemicals.
Kirkland D; Levy DD; LeBaron MJ; Aardema MJ; Beevers C; Bhalli J; Douglas GR; Escobar PA; Farabaugh CS; Guerard M; Johnson GE; Kulkarni R; Le Curieux F; Long AS; Lott J; Lovell DP; Luijten M; Marchetti F; Nicolette JJ; Pfuhler S; Roberts DJ; Stankowski LF; Thybaud V; Weiner SK; Williams A; Witt KL; Young R
Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():21-35. PubMed ID: 30744809
[TBL] [Abstract][Full Text] [Related]
19. Combinations of genotoxic tests for the evaluation of group 1 IARC carcinogens.
Bhagat J
J Appl Toxicol; 2018 Jan; 38(1):81-99. PubMed ID: 28695982
[TBL] [Abstract][Full Text] [Related]
20. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
